Closing Bell: Biosyent Inc up on Tuesday (RX)
Biosyent Inc opened trading today at $9.99 and closed at $10.16. It traded at a low of $9.99 to a high of $10.18.
The price advanced 0.59% from the previous day's close of $10.10.
During the day across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.
Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).
Trading volume was 3,151 on 18 total trades, with an average volume of 1,955 over 5 days.
The TSX-V market on the whole today saw 2,584 price advancers against 2,644 declines and 86 unchanged.
During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.46 (July 31,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have advanced 32.98%, while they have boosted 10.20% since the start of 2024.
It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.
Following today's trading, Biosyent Inc has a market capitalization of $117.00 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.
Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.
Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
